May 26, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Improving Adherence with Patient-Centric Formulations The term “patient centered,” “patient centric,” or “patient centricity” has increasingly grown in use in the scientific community in a wide variety of contexts. Generally, patient centric medicines are recognized...
Apr 15, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Controlled delivery formulations remain one of the favored tools for advancing the lifecycle of pharmaceutical products, and excipient selection is vitally important. A traditional strategy is to initially launch multiple daily doses of an immediate-release (IR)...
Apr 14, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Physiologically based pharmacokinetic modeling is well established in the pharmaceutical industry and is accepted by regulatory agencies for the prediction of drug–drug interactions. However, physiologically based pharmacokinetic modeling is valuable to address a much...
Apr 13, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Oral Peptide Therapeutics – Technologies have been honed to overcome many of the challenges of administering peptide therapeutics orally, but obstacles remain before drug developers can fully realize the vast potential. Numerous technologies are currently in...
Apr 12, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
There are various light-scattering tools available to the pharma/biotech industry. One such company ‘Wyatt Technology’, provides macromolecular and nanoparticle characterization solutions recognised by the FDA and several related technologies to their...
Recent Comments